Drugs@FDA application record, NDA 014103 (ONCOVIN, vincristine sulfate injection) (1963)

Government Record · U.S. Food and Drug Administration, Center for Drug Evaluation and Research · July 10, 1963

U.S. Food et al., 1963-07-10: FDA application record for Oncovin showing an original approval dated 10 July 1963 and Eli Lilly as holder, matching the company that patented the alkaloid (CHI-13).

07/10/1963

HTML record, unpaginated

U.S. Food et al., 1963-07-10: FDA application record for Oncovin showing an original approval dated 10 July 1963 and Eli Lilly as holder, matching the company that patented the alkaloid (CHI-13). Funder/conflicts: n/a. Maker: Eli Lilly and Co. Comparator: n/a. NCI's timeline lists vincristine (NSC 67574) as approved in 1963 (CHI-16). Study type: regulatory record.